Immediate Impact
1 from Science/Nature 73 standout
Citing Papers
Nano-enhanced immunotherapy: Targeting the immunosuppressive tumor microenvironment
2024 Standout
mTOR and neuroinflammation in epilepsy: implications for disease progression and treatment
2024 Standout
Works of Philipp Opfermann being referenced
A pilot study on reparixin, a CXCR1/2 antagonist, to assess safety and efficacy in attenuating ischaemia–reperfusion injury and inflammation after on-pump coronary artery bypass graft surgery
2014
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Philipp Opfermann | 241 | 164 | 199 | 33 | 501 | |
| Andreas Espinoza | 157 | 183 | 81 | 43 | 426 | |
| Gökhan Lafçı | 181 | 131 | 112 | 40 | 423 | |
| Ulla‐Stina Salminen | 271 | 132 | 160 | 37 | 554 | |
| Enrico Ferri | 213 | 181 | 95 | 40 | 546 | |
| Dietmar Böthig | 234 | 192 | 236 | 23 | 479 | |
| Ahmed H. Mohamed | 213 | 305 | 92 | 48 | 493 | |
| F. Iodice | 163 | 127 | 140 | 41 | 445 | |
| Xavier Bemtgen | 97 | 77 | 89 | 34 | 575 | |
| Bora Farsak | 227 | 212 | 99 | 40 | 529 | |
| Aurélien Bataille | 273 | 143 | 50 | 30 | 505 |
All Works
Login with ORCID to disown or claim papers
Loading papers...